A Case Report and Review of Transitional Cell Carcinoma in Children

Contact hours available until 4/30/2016.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation.

Faculty, Planners and Authors Conflict of Interest Disclosure:
The editor and education director reported no actual or potential conflict of interest in relation to this continuing nursing education article.

Pamela Ellsworth disclosed that she is a consultant on the Presenters’ Bureau for Pfizer; on the Advisory Board for Pfizer, Astellas, and Allergan; and has received financial support for a clinical trial from Pfizer. All other authors had no conflicts of interest to disclose.

Urologic Nursing Editorial Board Statements of Disclosure
Christine Bradway, PhD, CRNP, FAAN, disclosed that she is a Consultant for Direct Supply Inc., and on the Advisory Board for Myrbetriq. All other Editorial Board Members, as well as the Editor and Education Director, reported no actual or potential conflict of interest in relation to this continuing nursing education article.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

SUNA is a provider approved by the California Board of Registered Nursing, provider number, CEP 5556.

Objectives:

• Define transitional cell carcinoma (TCC).
• Explain the occurrence of TCC in children and adolescents.
• Discuss treatment options of TCC in the pediatric population.